Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients

por Pabinger, Ingrid, Lissitchkov, Toshko, Nagao, Asuza, Lepatan, Lynda Mae, Li, Yanyan, Seifert, Wilfried, Mancuso, Maria Elisa
Publicado 2023